Aprogen Medicines Inc. (KRX:007460)
South Korea
· Delayed Price · Currency is KRW 711.00
+27.00 (3.95%)
Last updated: Jun 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Medicine | 62.95B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medicine Growth | 93.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Steel | 46.01B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Steel Growth | 136.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hardfacing | 30.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hardfacing Growth | 124.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| NUKON | 3.83B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| NUKON Growth | 39.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biosimilar | 3.79B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biosimilar Growth | -59.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Game | 357.66M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Game Growth | 141.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 3.58B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 365.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufactured - Others | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufactured - Others Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Construction - NUKON | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Construction - NUKON Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufactured - Glycholine soft capsule | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufactured - Glycholine soft capsule Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Merchandised - Others | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Merchandised - Others Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufactured - Foam Glass | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufactured - Foam Glass Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufactured - Glutanex Injection | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufactured - Glutanex Injection Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service - Dragon Raja Origin | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| South Korea | 131.62B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | 91.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas | 18.96B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas Growth | 96.77% |
Log In |
Log In |
Log In |
Log In | Upgrade
|